WP 3 – Regulatory & Ethical

The Swedish Medical Products Agency (MPA, Läkemedelsverket) supports academic and business-related innovation activities and projects in respect of precision cancer health with timely regulatory, scientific and innovation advice in relation to oncology clinical trials.  

Key Activities & Deliverables:

  • Promote academic and business-related innovation activities by simplifying the availability of regulatory and scientific expertise.

  • Promote development, education and information on regulations based on knowledge building from international cooperation within the so-called "Regulatory science" area in regards of oncology precision health

  • Provide project specific innovation advice sessions.

  • Provide Consultations between MPA and the partners in the milieu with special focus on the testbed trials and co-development.

Previous
Previous

WP 2 – Precision Diagnostics

Next
Next

WP 4 – Data & Analytics